MarkNtel Advisors recently published a detailed industry analysis of the Carrier Screening Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
Carrier Screening Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2030
The Carrier Screening Market size was valued at around USD 2.09 billion in 2023 & is estimated to grow at a CAGR of around 20.7% during the forecast period, i.e., 2024–30.
What are the major Driver the Carrier Screening industry?
Rising Prevalence of Genetic Disorders – The increasing occurrence and understanding of genetic disorders are major factors driving the growth & expansion of carrier screening services. Carrier screening is a crucial methodology for pinpointing individuals who possess one copy of a gene mutation linked to a particular genetic ailment. Approximately 10,000 distinct types of single-gene diseases, also known as monogenic diseases, exist, wherein mutations in a single gene cause the ailment. According to the World Health Organization Report, it has been estimated that 9 out of every 999 individuals are adversely impacted by these conditions. This suggests that about 85 million people are grappling with one of these diseases worldwide.
Furthermore, the escalating incidence of hereditary cancer stands as a significant catalyst for market growth. Carrier screening, especially concerning genes linked to cancer susceptibility, holds vital importance in identifying individuals carrying genetic mutations associated with heightened risks of specific cancer types. For example, according to the NIH, as much as 10% of all cancers might stem from inherited genetic alterations. Thus, the increasing prevalence of genetic disorders emphasizes the critical role of carrier screening as both a preventive measure and a means for informed decision-making in family planning. As awareness expands, the market is poised to assume an increasingly pivotal role in the management and prevention of genetic diseases.
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/carrier-screening-market.html
What segments define the Carrier Screening market from 2024 to 2030? How do these segments contribute to market dynamics and growth?
- By Product & Service
- Services- Market Size & Forecast 2019-2030, (USD Million)
- Products- Market Size & Forecast 2019-2030, (USD Million)
- By Type
- Expanded Carrier Screening- Market Size & Forecast 2019-2030, (USD Million)
- Predesigned Panel Testing- Market Size & Forecast 2019-2030, (USD Million)
- Customized Panel Testing- Market Size & Forecast 2019-2030, (USD Million)
- Targeted Disease Carrier Screening- Market Size & Forecast 2019-2030, (USD Million)
- Expanded Carrier Screening- Market Size & Forecast 2019-2030, (USD Million)
According to report, the targeted disease carrier screening segment is set to hold a major share of the market throughout the forecast period in the carrier screening industry.
- By Medical Condition
- Pulmonary Conditions- Market Size & Forecast 2019-2030, (USD Million)
- Hematological Conditions- Market Size & Forecast 2019-2030, (USD Million)
- Neurological Conditions- Market Size & Forecast 2019-2030, (USD Million)
- Others- Market Size & Forecast 2019-2030, (USD Million)
According to report, among all, the hematologic conditions segment holds a major share of the market and is projected to experience substantial market expansion during the forecast period as well.
- By Technology
- DNA Sequencing- Market Size & Forecast 2019-2030, (USD Million)
- PCR- Market Size & Forecast 2019-2030, (USD Million)
- DNA Microarrays- Market Size & Forecast 2019-2030, (USD Million)
- Others- Market Size & Forecast 2019-2030, (USD Million)
- By End-User
- Hospitals & Medical Centers- Market Size & Forecast 2019-2030, (USD Million)
- Clinical Laboratories- Market Size & Forecast 2019-2030, (USD Million)
- Fertility Clinics- Market Size & Forecast 2019-2030, (USD Million)
- Others- Market Size & Forecast 2019-2030, (USD Million)
Explore the Complete Carrier Screening Market Analysis Report – https://www.marknteladvisors.com/research-library/carrier-screening-market.html
Geographical Analysis: Carrier Screening Market
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Carrier Screening Market Share & Competitive Landscape:
The Carrier Screening Market is characterized by intense competition, with several key players driving growth through innovation, market expansion, and strategic investments. The competitive landscape provides valuable insights into the industry’s leading companies, highlighting their strengths, financial performance, and market influence.
Leading Companies in the Carrier Screening Market are:
- NATERA, INC.
- QUEST DIAGNOSTICS INCORPORATED
- FULGENT GENETICS
- INVITAE CORPORATION
- EUROFINS SCIENTIFIC
- OPKO HEALTH, INC.
- THERMO FISHER SCIENTIFIC INC.
- MYRIAD GENETICS, INC.
- ILLUMINA, INC.
- CENTOGENE N.V.
- DIASORIN S.P.A.
- OTOGENETICS
- GENETECH
- LABORATORY CORPORATION OF AMERICA HOLDINGS
Carrier Screening Industry Recent Development:
- 2022: OPKO Health Inc. completed the acquisition of ModeX Therapeutics, intending to utilize proprietary immunotherapy technology for the treatment of cancerous and infectious diseases under the Oncology department.
Questions Addressed in this Study
1.What factors are driving the Carrier Screening Market growth?
2.How is the Carrier Screening Market expected to grow over the next five years?
3.What are the key insights into the current trends in the Carrier Screening Market?
4.What is the current size of the Carrier Screening Market, and how is it projected to change in the future?
6.What is the future outlook for the Carrier Screening Market in terms of technological advancements and market expansion?
For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/carrier-screening-market.html
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
More Research Studies Report:
–Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 16%.
–Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
